Researchers launch major tissue bank to unlock secrets of mesothelioma

NCT ID NCT01950572

First seen Jun 25, 2026 · Last updated Aug 07, 2026 · Updated 7 times

Summary

This study aims to collect blood, urine, tumor samples, and health data from up to 1,000 people with malignant mesothelioma or other cancers that express a protein called mesothelin. Participants will be followed over time to track the course of their disease. The goal is to build a resource for future research, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could help researchers better understand mesothelioma and related cancers, potentially pointing toward new treatments in the future.
What could go wrong
This is an observational study, not a treatment trial. It does not test any new drug or therapy, so there is no direct benefit to participants. Results may take years to emerge.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BILIARY ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • National Institutes of Health Clinical Center

    RECRUITING

    Bethesda, Maryland, 20892, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.